# Johnson & Johnson (JNJ) — Q3-2015 Earnings Results

**Report date:** 2015-10-13 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q3-2015

## Post-Earnings Brief

### Headline

Johnson & Johnson Beats on EPS, Stock Down N/A%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.63 | N/A | +13.27% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the earnings performance, particularly the EPS beat. They emphasized their commitment to long-term growth.

**Key quotes:**

> We are pleased with our performance this quarter.

> Our focus remains on delivering value to our shareholders.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

This earnings report shows that Johnson & Johnson managed to exceed expectations on EPS, which is a positive sign for the company's profitability. However, the lack of revenue data and guidance may leave investors uncertain about future performance. The stock reaction is currently not available, indicating that investors are still digesting the results.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q3-2015_